Naprod Life Sciences Private Limited — Docetaxel Exporter Profile
Indian Pharmaceutical Exporter · #13 for Docetaxel · $608.8K export value · DGFT Verified
Naprod Life Sciences Private Limited is the #13 Indian exporter of Docetaxel with $608.8K in export value and 41 verified shipments. Naprod Life Sciences Private Limited holds a 1.5% market share in Docetaxel exports across 14 countries. The company exports 23 pharmaceutical products worth $18.7M across 4 therapeutic categories.
Naprod Life Sciences Private Limited — Docetaxel Export Profile: Buyers & Destinations
Where Does Naprod Life Sciences Private Limited Export Docetaxel?
| Country | Value | Shipments | Share |
|---|---|---|---|
| PHILIPPINES | $217.1K | 8 | 33.7% |
| BRAZIL | $113.8K | 4 | 17.7% |
| TRINIDAD & TOBAGO | $48.6K | 1 | 7.5% |
| ZIMBABWE | $41.4K | 8 | 6.4% |
| KENYA | $35.4K | 4 | 5.5% |
| PANAMA | $35.1K | 1 | 5.5% |
| ECUADOR | $34.3K | 1 | 5.3% |
| INDONESIA | $26.3K | 2 | 4.1% |
| VIETNAM DEMOCRATIC REP OF | $24.0K | 1 | 3.7% |
| MEXICO | $23.0K | 1 | 3.6% |
Naprod Life Sciences Private Limited exports Docetaxel to 16 countries. The largest destination is PHILIPPINES accounting for 33.7% of Naprod Life Sciences Private Limited's Docetaxel shipments, followed by BRAZIL (17.7%) and TRINIDAD & TOBAGO (7.5%). These destinations reflect Naprod Life Sciences Private Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Docetaxel from Naprod Life Sciences Private Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| MULTICARE PHARMACEUTICALS PHILIPPIN | PHILIPPINES | $179.6K | 6 |
| LABORATORIO QUIMICO FARMACEUTICO | BRAZIL | $113.8K | 4 |
| MINISTRY OF HEALTH C/O | TRINIDAD & TOBAGO | $48.6K | 1 |
| MULTICARE PHARMACEUTICALS PHILIPPI | PHILIPPINES | $37.4K | 2 |
| RIPPLE PHARMACUTICALES LTD, | KENYA | $35.4K | 2 |
| INSTITUTO ONCOLOGICO NACIONAL JUAN DEMOSTENES AROS EMENADEPOSITODE FARMACIA | PANAMA | $35.1K | 1 |
| MINISTERIO DE SALUD PUBLICA | ECUADOR | $34.3K | 1 |
| PT, KIMIA FARMA TBK, | INDONESIA | $26.3K | 2 |
| CENTRAL PHARMACEUTICAL JOINT | VIETNAM DEMOCRATIC REP OF | $24.0K | 1 |
| GABAME WH | MEXICO | $23.0K | 1 |
Naprod Life Sciences Private Limited supplies Docetaxel to 23 buyers globally. The largest buyer is MULTICARE PHARMACEUTICALS PHILIPPIN (PHILIPPINES), followed by LABORATORIO QUIMICO FARMACEUTICO (BRAZIL) and MINISTRY OF HEALTH C/O (TRINIDAD & TOBAGO). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Docetaxel Export Value and How Much Does Naprod Life Sciences Private Limited Contribute?
India exported $22.4M worth of Docetaxel through 2,634 shipments from 253 suppliers to 120 countries, serving 641 buyers globally. Naprod Life Sciences Private Limited contributes $608.8K to this total, accounting for 1.5% of India's Docetaxel exports. Naprod Life Sciences Private Limited ships Docetaxel to 16 countries through 23 buyers.
What Is the Average Shipment Value for Naprod Life Sciences Private Limited's Docetaxel Exports?
Naprod Life Sciences Private Limited's average Docetaxel shipment value is $14.8K per consignment, based on 41 shipments totaling $608.8K. The largest destination is PHILIPPINES (33.7% of Naprod Life Sciences Private Limited's Docetaxel exports).
How Does Naprod Life Sciences Private Limited Compare to Other Indian Docetaxel Exporters?
Naprod Life Sciences Private Limited ranks #13 among 253 Indian Docetaxel exporters with a 1.5% market share. The top 3 exporters are FRESENIUS KABI ONCOLOGY LIMITED ($8.4M), MYLAN LABORATORIES LIMITED ($3.5M), INTAS PHARMACEUTICALS LIMITED ($2.2M). Naprod Life Sciences Private Limited processed 41 shipments to 14 destination countries.
What Docetaxel Formulations Does Naprod Life Sciences Private Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| KOKSARA (DOCETAXEL FOR INJECTION CONCENT | $113.8K | 4 |
| TACEEDO-80 COMBIPACK (DOCETAXEL INJECTION USP CONCENTRATE 80MG/2ML) (2000 VIALS)VLS | $49.8K | 1 |
| TACEEDO 80 COMBIPACK DOCETAXEL INJECTION USP CONCENTRATE 80MG 2ML 2000 VIALS | $48.8K | 1 |
| DOCETAXEL INJECTION USP CONCENTRATE 80MG/2ML (DOCETAXEL INJECTION USP CONCENTRATE 80MG/2ML(7471 VIALS) | $48.6K | 1 |
| TACEEDO-80 COMBIPACK DOCETAXEL INJECTIO | $37.9K | 1 |
| DOCETAXEL INJECTION USP CONCENTRATE 80MG | $37.5K | 2 |
| DOCETAXEL INJECTION USP CONCENTRATE 80MG/2ML DOCETAXEL INJECTION USP CONCENTRATE 80MG/2ML5112 VIALS | $35.1K | 1 |
| Docetaxel Injection USP Concentrate 80mg | $26.2K | 5 |
| TACEEDO-80 COMBIPACK DOCETAXEL INJECTION USP CONCENTRATE 80MG/2ML | $25.4K | 1 |
| TACEEDO 80 COMBIPACK DOCETAXEL FOR INJECTION CONCENTRATE 80MG 2948 VIALS | $24.0K | 1 |
Naprod Life Sciences Private Limited exports 33 distinct Docetaxel formulations including tablets, capsules, syrups, and combination drugs. The top formulation is KOKSARA (DOCETAXEL FOR INJECTION CONCENT with 4 shipments worth $113.8K.
Regulatory Requirements: Exporting Docetaxel to Key Markets
What Naprod Life Sciences Private Limited must comply with to export Docetaxel to its top destination countries
Brazil — ANVISA
Approval Process
Generic registration under RDC 200/2017. ANVISA GMP inspection of Indian facility mandatory before approval.
Timeline: 12–24 months
GMP & Export Requirements
ANVISA GMP certificate (CBPF) for each manufacturing site; on-site inspection by ANVISA
Certificate of Pharmaceutical Product from CDSCO; Import Authorization via SISCOMEX
Note: ANVISA maintains active Indian pharma facility inspection program. Inspection backlog can extend timelines.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Naprod Life Sciences Private Limited Compare to Nearest Docetaxel Exporters?
Exporters ranked immediately above and below #13 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 5 | JODAS EXPOIM PRIVATE LIMITED | $700.0K | 14 | 1 | $50.0K |
| 7 | ALEMBIC PHARMACEUTICALS LIMITED | $700.0K | 14 | 1 | $50.0K |
| 13 | NAPROD LIFE SCIENCES PRIVATE LIMITED ★ | $608.8K | 41 | 14 | $14.8K |
| 6 | ZYDUS HOSPIRA ONCOLOGY PRIVATE LIMITED | $600.0K | 12 | 4 | $50.0K |
| 14 | THERDOSE PHARMA PRIVATE LIMITED | $490.0K | 29 | 6 | $16.9K |
Naprod Life Sciences Private Limited ranks #13 among 253 Indian Docetaxel exporters. Average shipment value of $14.8K compared to the market average of $88.6K. The closest competitors by value are JODAS EXPOIM PRIVATE LIMITED and ALEMBIC PHARMACEUTICALS LIMITED.
Which Indian Ports Ship Docetaxel Exports?
| Port | Shipments | % Share |
|---|---|---|
| DELHI AIR CARGO ACC (INDEL4) | 530 | 20.1% |
| DELHI AIR | 416 | 15.8% |
| SAHAR AIR CARGO ACC (INBOM4) | 379 | 14.4% |
| SAHAR AIR | 372 | 14.1% |
| Bombay Air | 132 | 5.0% |
| Delhi Air | 90 | 3.4% |
| HYDERABAD AIR | 79 | 3.0% |
| HYDERABAD ACC (INHYD4) | 54 | 2.1% |
What Other Oncology Products Does Naprod Life Sciences Private Limited Export?
Naprod Life Sciences Private Limited also exports these oncology products. Each links to the detailed product page.
About Naprod Life Sciences Private Limited
Naprod Life Sciences Private Limited exports 23 products worth $18.7M. Beyond Docetaxel, top products include Carboplatin, Fluorouracil, Oxaliplatin, Methotrexate, Gemcitabine. View the complete Naprod Life Sciences Private Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Docetaxel — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Docetaxel shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Naprod Life Sciences Private Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 44 individual customs records matching Naprod Life Sciences Private Limited exporting Docetaxel, covering 33 formulations to 16 countries via 23 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 120+ countries, 641+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Docetaxel Export Data from Naprod Life Sciences Private Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Naprod Life Sciences Private Limited's Docetaxel exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Naprod Life Sciences Private Limited
Full Company Profile →
23 products · $18.7M total trade · 4 categories
Docetaxel Stats
Company Overview
Top Products by Naprod Life Sciences Private Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Naprod Life Sciences Private Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Docetaxel. For current shipment-level data, contact TransData Nexus.